John Aucott, MD
Medical Director, Medicine
Lyme Disease Clinical Research Center, Department of Medicine,
Johns Hopkins University School of Medicine
Persistent Symptoms of Lyme Disease
Dr. Aucott is a graduate of the University of California, Berkeley. He attended the Johns Hopkins University School of Medicine where he graduated Alpha Omega Alpha, and is a diplomate of the American Board of Internal Medicine with sub-specialty training in Infectious Disease and Geographic Medicine at University Hospitals of Cleveland.
Dr. Aucott joined the faculty at Johns Hopkins School of Medicine in 1996 where his focus has been on clinical research in Lyme disease. In 2015 Dr. Aucott joined the Division of Rheumatology at Johns Hopkins where he is an Associate Professor of Medicine and the Director of the Johns Hopkins Lyme Disease Research Center. He is principal investigator for the SLICE studies examining the long-term outcomes of Lyme disease. The longitudinal cohorts of patients in enrolled in his studies have resulted in a biorepository of blood samples that is a national resource for research collaboration.
Dr. Aucott’s research interests center on the pathophysiology, diagnosis and treatment of post-treatment Lyme disease and has resulted in over 70 peer reviewed publications. His research program has resulted in the development of several diagnostic tests currently used in the United States. He has four patent applications for diagnostics in Lyme disease.
Dr. Aucott is the program director for the Lyme and Tickborne Diseases Fellowship training program at Johns Hopkins. He speaks to both physician and patient groups on Lyme and tickborne diseases. He maintains an active clinical practice of medicine and Lyme disease.
Dr. Aucott is an internationally recognized authority on Lyme disease and has served on groups sponsored by the Institute of Medicine, the Canadian Institutes of Health Research, the American Academy for the Advancement of Science and the U.S. Department of Health and Human Services where he was the Chair of the 2018-2019 HHS Tick-borne Diseases Working Group.